NCT06072365View on ClinicalTrials.gov

Treatment With Elexacaftor/Tezacaftor/Ivacaftor, in Patients With Cystic Fibrosis and Caloric Intake

CompletedOBSERVATIONAL
Enrollment

120

Participants

Timeline

Start Date

October 21, 2021

Primary Completion Date

September 23, 2022

Study Completion Date

January 15, 2023

Conditions
Cystic Fibrosis
Interventions
OTHER

nutritional intake questionnaire

patients completed a nutritional intake questionnaire before to start the treatment, 3mounths after and twelve months after

Trial Locations (3)

31059

UHToulouse, Toulouse

33404

UHBordeaux, Bordeaux

87042

UHLimoges, Limoges

All Listed Sponsors
lead

University Hospital, Toulouse

OTHER

NCT06072365 - Treatment With Elexacaftor/Tezacaftor/Ivacaftor, in Patients With Cystic Fibrosis and Caloric Intake | Biotech Hunter | Biotech Hunter